Fate Therapeutics Inc FATE

NAS: FATE | ISIN: US31189P1021 30/04/2025

1,280 USD (+9,40%)

(+9,40%) 30/04/2025

Grafiek Fate Therapeutics Inc

Grafiek Fate Therapeutics Inc

1 dag1d 9,40%
1 week1w -5,19%
1 maand1m 69,07%
3 maanden3m 0,79%
6 maanden6m -47,33%
1 jaar1j -68,70%
5 jaar5j -95,19%

Fate Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

2 maart 2023 · FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit · Persbericht

9 februari 2023 · FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit · Persbericht

1 februari 2023 · Bronstein, Gewirtz & Grossman, LLC Notifies Fate Therapeutics, Inc. (FATE) Investors of Class Action and to Actively Participate · Persbericht

28 januari 2023 · INVESTOR NOTICE: Fate Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FATE · Persbericht

8 maart 2021 · Fate Therapeutics to Present at Upcoming Investor Conferences · Persbericht

24 februari 2021 · Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational Progress · Persbericht

22 februari 2021 · Fate Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference · Persbericht

19 februari 2021 · Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2020 Financial Results · Persbericht

8 januari 2021 · Fate Therapeutics Announces Completion of Public Offering of Common Stock and Pre-Funded Warrants, and Full Exercise of Underwriters’ Option to Purchase Additional Shares · Persbericht

6 januari 2021 · Fate Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants · Persbericht

Profiel Fate Therapeutics Inc

Gezondheidstechnologie

Productie van biologische producten

Website: fatetherapeutics.com

Hoofdzetel: San Diego, California Verenigde Staten

CEO: John Wolchko

Werknemers: 482

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe